[
  {
    "ts": "2026-02-23T11:00:00+00:00",
    "headline": "IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer",
    "summary": "IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D a",
    "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-appointment-dr-110000638.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "2a2a216a-88c8-33f7-bf2a-0ed4f9bbd841",
      "content": {
        "id": "2a2a216a-88c8-33f7-bf2a-0ed4f9bbd841",
        "contentType": "STORY",
        "title": "IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer",
        "description": "",
        "summary": "IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D a",
        "pubDate": "2026-02-23T11:00:00Z",
        "displayTime": "2026-02-23T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b53b2c167935532309987db78b249c89",
          "originalWidth": 400,
          "originalHeight": 261,
          "caption": "(PRNewsfoto/IDEAYA Biosciences, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/smKChLwQ.SonclD79zSdzg--~B/aD0yNjE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b53b2c167935532309987db78b249c89.cf.webp",
              "width": 400,
              "height": 261,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R0fazI2CBgEFiEDtnaOWYg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b53b2c167935532309987db78b249c89.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-appointment-dr-110000638.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-appointment-dr-110000638.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDYA"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]